Warning
The Harvard Drug Group LLC Recalls Carton Label: MAJOR
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0609-2026Drug / Pharmaceutical
The Harvard Drug Group LLC Recalls Carton Label: MAJOR
The Harvard Drug Group LLC · Class II — Moderate Risk
Product Description
Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.
Reason for Recall
Subpotent Drug
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
U.S. Nationwide.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. The Harvard Drug Group LLC initiated the recall on June 16, 2026 affecting 790 Cartons. Subpotent Drug. The product was distributed in U.S. Nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact The Harvard Drug Group LLC for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.